HOOKIPA Pharma Inc. Income Statement

Ask AI

Financial Statements

In millions of USD, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Revenue from collaboration and licensing
Operating expenses:
Research and development
General and administrative
Restructuring
Impairment
Total operating expenses
Loss from operations
Other income (expense):
Grant income
Interest income
Interest expense
Other (expense) income, net
Total other income, net
Net loss before tax
Income tax expense
Net loss
Other comprehensive loss:
Foreign currency translation (loss) gain, net of tax
Comprehensive loss
Net loss per share - basic and diluted
Net loss per share - basic
Net loss per share - diluted

Comments